On this page
CloudHealth was, for years, the default answer to "we need a cloud cost platform." It has one of the largest installed bases in FinOps, mature policy governance, and a deep MSP and partner ecosystem. None of that has disappeared. What has changed is the context around it — and 2026 is the year that context turns into migrations.
This guide covers three things: why teams are actually leaving (with the documented reasons, not vendor FUD), what to demand from a replacement in 2026, and how to run a candidate in parallel — read-only — so the decision is made on your own bill rather than on a demo dataset.
Why teams are re-evaluating CloudHealth in 2026
1. Post-acquisition uncertainty. Since Broadcom acquired VMware (and CloudHealth with it) in late 2023, customers and analysts have described pricing as "in flux", the roadmap as unclear, and product updates as slower. Whether or not the product itself degrades, procurement teams price uncertainty — and multi-year commitments to a platform whose ownership strategy is unclear are a hard internal sell.
2. The VMware halo effect. Surveys of VMware customers in 2025-2026 found roughly 86% actively working to reduce their VMware footprint, with 2025 widely described as the planning year and 2026 as the migration year (CIO Dive, The Register). That defiance contaminates CloudHealth even where the FinOps product is not the direct cause: if your organization is exiting the Broadcom estate anyway, the cost platform rides along.
3. Product gaps that newer tools have closed. The recurring complaints from users and competitive teardowns are consistent: limited Kubernetes and container cost attribution, weak showback/chargeback, data lag versus near-real-time competitors, and an automation story that recommends but does not execute. AI/LLM spend — which 98% of organizations now manage according to the State of FinOps 2026 — is essentially absent.
4. The pricing model itself. CloudHealth charges a base fee covering up to $100k/month of AWS spend, with a minimum around $1,000/month (≈ $41,904/year on a 12-month term), plus roughly 3% of any spend above the threshold. AWS Marketplace tiers have been documented at $45k/year (CH150K), $90k (CH300K) and $150k (CH500K), with ~12% discounts for 36-month commitments (Finout teardown). The structural objection is the same one levelled at every %-of-spend platform: your tooling bill grows with your cloud bill, with no new value attached.
What to demand from a replacement in 2026
Evaluation criteria have moved since most CloudHealth contracts were signed. Frameworks like the ISG FinOps Buyers Guide 2025 and current practitioner checklists converge on a short list:
- FOCUS-native billing data. FOCUS 1.2 was ratified in May 2025 and 1.3 in December 2025; 68% of organizations spending $100M+ already use or pilot FOCUS-formatted data. A tool that cannot ingest or emit FOCUS will fight every other tool in your stack. (See our FOCUS explainer.)
- Execution, not just recommendations. A dashboard of stale findings saves exactly $0. Look for remediation behind an approval workflow, with an audit trail — not a CSV export of "opportunities".
- Verification of findings. False positives are why engineers mute cost alerts. Ask vendors how findings are validated before they reach a human.
- Kubernetes and AI spend in the same plane. Container attribution and LLM/GPU cost tracking are no longer adjacent products; AI cost management is the #1 skill FinOps teams are hiring for (58%, State of FinOps 2026).
- Time-to-value measured in minutes. The market norm is now a read-only connection and a first savings report the same day. Multi-week onboarding is a legacy pattern.
- Pricing you can predict. Flat tiers anchored to spend bands (Finout, Vantage, Cloudios) versus %-of-spend (CloudZero, Cloudability, CloudHealth overage). Model both at your projected growth, not your current bill.
The main alternatives, honestly compared
Every vendor (including us) writes this table self-servingly. Here is the version we would want to read, based on public pricing pages, verified contract data from Vendr, and documented product scope. A "—" means we could not verify the capability from public information.
| Vendor | Pricing model | Strongest at | Watch out for |
|---|---|---|---|
| CloudZero | %-of-spend, sales-led (median contract $78.4k/yr across 37 verified Vendr purchases) | Unit economics: cost per customer/feature, flexible ingestion | Read-only by design — no remediation; annual contracts only |
| Vantage | Flat tiers: free (≤$2.5k/mo tracked) to $200/mo, then enterprise; Autopilot add-on at 5% of savings | Product-led onboarding, 20+ providers, clean reporting | Action limited to AWS commitments; users capped per tier; no carbon dimension |
| Finout | Flat: $1,000/mo (≤$500k/yr spend) or $2,000/mo (≤$2M/yr), unlimited users | Allocation across cloud + SaaS, low-touch onboarding | Showback/chargeback focus — enforcement and remediation are not the product |
| nOps | Fixed fee for visibility + share-of-savings for rate optimization | AWS rate optimization (commitments), marketplace procurement | AWS-centric; savings-share fee scales with what it touches |
| ProsperOps | 30–35% of realized savings (negotiable to 20–28% at $5M+/yr) | Autonomous commitment management, measured by provider billing | Commitments only — not a full cost platform; the fee is the steepest in the category |
| Cloudios | Flat self-serve tiers from €0, no sales call | AI-verified findings across 9 clouds, gated remediation, AI budget enforcement, carbon per recommendation | Younger platform; MSP/partner ecosystem is not at CloudHealth depth |
A useful mental model: CloudZero/Finout/Vantage compete on seeing costs better; ProsperOps/nOps compete on automating one lever (commitments); Cloudios competes on closing the loop — verify the finding, then fix it behind an approval, and extend the same discipline to AI spend and carbon. Which gap matters most depends on why you are leaving CloudHealth in the first place.
How to test a replacement without ripping anything out
The good news about cost platforms: they read the same billing data. You do not need a migration project to evaluate one — you need a read-only IAM role and a comparison window. The pattern that works:
- Check your renewal date first. CloudHealth contracts are typically annual or 36-month with auto-renewal. Count backwards: a fair parallel test needs 30–60 days, plus procurement time. If renewal is closer than that, negotiate a short extension rather than rushing the evaluation.
- Connect the candidate read-only. Every serious platform connects via a read-only cross-account role (AWS), reader role (Azure) or viewer + billing export (GCP). No agent, no write permissions. If a vendor needs write access to show you findings, that is your answer.
- Compare findings on the same bill, same month. Export CloudHealth recommendations and put them next to the candidate's findings. Score three things: coverage (what did each one see?), accuracy (sample 10 findings each and verify them by hand — false-positive rate is the metric that predicts whether engineers will trust the tool), and actionability (how many clicks from finding to fix?).
- Re-create your top 5 reports, not all of them. Perspectives and policies accumulated over years are mostly dead weight. Rebuild the showback views and budgets people actually open; treat the rest as an archive export.
- Run one remediation end-to-end in a sandbox account. If the replacement claims to execute fixes, verify the approval workflow, the rollback story, and the audit log before anyone touches production.
- Only then talk price. With a verified savings number from your own bill, you are negotiating from evidence — against the incumbent and the challenger.
Bottom line
Leaving CloudHealth is not automatically the right call — but in 2026, *not re-evaluating it* is hard to defend. The evaluation costs you a read-only role and a month of parallel running. Whatever you choose, demand FOCUS support, verified findings, remediation that executes, and a price that does not scale with your cloud bill by default.
If you want to see what that looks like in practice, the Cloudios vs CloudHealth comparison maps every claim above to a shipped feature, and the live demo requires no sign-up at all.